AntiHuman Mu-type opioid receptor/OPRM1/μOR Antibody (BMS986122)
The AntiHuman Mu-type opioid receptor/OPRM1/μOR Antibody (BMS986122) is a highly specific and potent antibody designed for the detection of the mu-opioid receptor (MOR) protein in human samples. This antibody is produced using advanced biotechnology techniques and has been extensively tested for its specificity and sensitivity.
Biological Function
The mu-opioid receptor is a G protein-coupled receptor that plays a crucial role in the analgesic effects of opioids. It is primarily found in the central nervous system and is responsible for mediating the pain-relieving and euphoric effects of opioids. The AntiHuman Mu-type opioid receptor/OPRM1/μOR Antibody binds to the MOR protein, allowing for the detection and study of this important receptor.
Main Applications
This antibody is an essential tool for researchers studying the mu-opioid receptor and its role in pain management, addiction, and other neurological disorders. It can also be used in drug development studies, as the MOR is a target for many pain-relieving medications. Additionally, this antibody can be used in diagnostic assays to detect the presence of the MOR protein in patient samples.
Experimental Use Cases
The AntiHuman Mu-type opioid receptor/OPRM1/μOR Antibody has been successfully used in various experimental settings. In one study, it was used to investigate the expression of the MOR protein in different regions of the brain and its correlation with pain perception. In another study, this antibody was used to evaluate the effectiveness of a potential MOR-targeting drug in a preclinical model of neuropathic pain.
With its high specificity and sensitivity, the AntiHuman Mu-type opioid receptor/OPRM1/μOR Antibody is a valuable tool for scientists and researchers in the field of biotechnology and neuroscience. Its ability to specifically detect the MOR protein makes it an essential component in understanding the mechanisms of opioid action and developing new treatments for pain and addiction.
Research Target: AntiHuman Mu-type opioid receptor/OPRM1/μOR Antibody, biotech products, MOR protein, pain management, addiction, neurological disorders, drug development, diagnostic assays, experimental settings, brain regions, pain perception, neuropathic pain, biotechnology, neuroscience, opioid action, treatment, specificity, sensitivity.
There are no reviews yet.